Biblio

Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is O  [Clear All Filters]
2014
Middeke JM, Fang M, Cornelissen JJ, Mohr B, Appelbaum FR, Stadler M, Sanz J, Baurmann H, Bug G, Schäfer-Eckart K, et al. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Blood. 2014.
Kato M, Manabe A, Saito AM, Koh K, Inukai T, Ogawa C, Goto H, Tsuchida M, Ohara A. Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG). Int J Hematol. 2014.
Skalska-Sadowska J, Wachowiak J, Skalska-Sadowska J, Wachowiak J, Zając-Spychała O, Niewiadomska-Wojnałowicz I, Januszkiewicz-Lewandowska D, Balwierz W, Pawińska-Wąsikowska K, Goździk J, et al. Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005-2011 - experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG). Contemp Oncol (Pozn). 2014;18(1):48-53.
Auger-Quittet S, Duny Y, Daures J-P, Quittet P. Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis. Cancer Med. 2014.
Lund TC, Cathey SS, Miller WP, Eapen M, Andreansky M, Dvorak CC, Davis JH, Dalal JD, Devine SM, Eames GM, et al. Outcomes after Hematopoietic Stem Cell Transplant for Children with I-Cell Disease. Biol Blood Marrow Transplant. 2014.
Haines HL, Bleesing JJ, Davies S, Hornung L, Jordan MB, Marsh RA, Filipovich AH. Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism Following a Reduced Intensity Preparative Regimen for Pediatric Patients with Non-Malignant Diseases. Biol Blood Marrow Transplant. 2014.
Alimoghaddam K, Jalali A, Aliabadi LSharifi, Ghaffari F, Maheri R, Eini E, Mashhadireza M, Mousavi SAsadollah, Bahar B, Jahani M, et al. The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience. Int J Hematol Oncol Stem Cell Res. 2014;8(2):9-13.
Malhotra P, Bodh V, Murthy GSubramania, Datta AKumar, Varma N, Varma S. Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia. Hematology. 2014.
Ghanem H, Garcia-Manero G, Faderl S, Ravandi F, Cortes J, Katragadda L, O'Brien S, Daver N, Pierce S, Kadia T, et al. Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure. Ther Adv Hematol. 2014;5(2):29-34.
Allareddy V, Roy A, Rampa S, Lee MK, Nalliah RP, Allareddy V, Rotta AT. Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States. Bone Marrow Transplant. 2014.
Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, et al. Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS One. 2014;9(1):e84941.
Haygood CLWalters, Arend RC, J Straughn M, Buchsbaum DJ. Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?. World J Stem Cells. 2014;6(4):441-7.
Hanna CB, Hennebold JD. Ovarian germline stem cells: an unlimited source of oocytes?. Fertil Steril. 2014;101(1):20-30.
Bresters D, Emons JAM, Nuri N, Ball LM, Kollen WJW, Hannema SE, Bakker-Steeneveld JDJ, van der Bom JG, Oostdijk W. Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood. Pediatr Blood Cancer. 2014.
Sun X, Terakawa J, Clevers H, Barker N, Daikoku T, Dey SK. Ovarian LGR5 is critical for successful pregnancy. FASEB J. 2014.
Anderson AS, Roberts PC, Frisard MI, Hulver MW, Schmelz EM. Ovarian tumor-initiating cells display a flexible metabolism. Exp Cell Res. 2014.
Tewari D, Khan MParvez, Sagar N, China SP, Singh AK, Kheruka SC, Barai S, Tewari MC, Nagar GK, Vishwakarma AL, et al. Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site. Stem Cell Rev. 2014.
Ma MR, Hui L, Wang ML, Tang Y, Chang YW, Jia QH, Wang XH, Yan W, Ha XQ. Overall codon usage pattern of enterovirus 71. Genet Mol Res. 2014;13(1):336-43.
Zakrzewski JL, van den Brink MRM, Hubbell JA. Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014.
Sugimoto H, Kondo S, Tanaka T, Imamura C, Muramoto N, Hattori E, Ogawa K'ichi, Mitsukawa N, Ohto C. Overexpression of a novel Arabidopsis PP2C isoform, AtPP2CF1, enhances plant biomass production by increasing inflorescence stem growth. J Exp Bot. 2014.
Zhu J, Thakolwiboon S, Liu X, Zhang M, Lubman DM. Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment. PLoS One. 2014;9(12):e115507.
Tamaki S, Tokumoto Y. Overexpression of cyclin dependent kinase inhibitor P27/Kip1 increases oligodendrocyte differentiation from induced pluripotent stem cells. In Vitro Cell Dev Biol Anim. 2014.
Dahlhoff M, Frances D, Kloepper JE, Paus R, Schäfer M, Niemann C, Schneider MR. Overexpression of epigen during embryonic development induces reversible, EGFR-dependent sebaceous gland hyperplasia. Mol Cell Biol. 2014.
Svoboda LK, Harris A, Bailey NJ, Schwentner R, Tomazou E, von Levetzow C, Magnuson B, Ljungman M, Kovar H, Lawlor ER. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs. Epigenetics. 2014;9(12):1613-1625.
Wong MMei, Yin X, Potter C, Yu B, Cai H, Di Bernardini E, Xu Q. Over-Expression of HSP47 Augments Mouse Embryonic Stem Cell Smooth Muscle Differentiation and Chemotaxis. PLoS One. 2014;9(1):e86118.

Pages